Email Newsletters

MetroWest

New CEO At Boston-Power

Westborough-based lithium-ion battery maker Boston-Power Inc. has named Keith Schmid as its new CEO, as former CEO...

PLC Sells Division For $1M

Franklin-based PLC Systems Inc. has completed the previously announced $1-million sale of its cardiac medical device division...

New Leadership Plan At TJX

Carol Meyrowitz has a new two-year contract as CEO of Framingham-based TJX Cos. In addition, the company...

Another Tough Year Predicted For BSX

Natick-based Boston Scientific Corp. eked out a $236-million profit during the fourth quarter, despite a decrease in...
ADVERTISEMENT

Genzyme Completes Diagnostics Sale

Genzyme, the Cambridge-based pharmaceutical company with major Central Massachusetts operations, has completed the $265 million sale of...

Genzyme Grants Sanofi Due Diligence Access

French drug maker Sanofi-Aventis has gotten one step closer to acquiring Genzyme Corp., with Genzyme's board authorizing...

Phase One Nears Completion On Berlin Project

   The first phase of a $70 million, five-year commercial-residential development named Riverbridge in Berlin is set...

FDA Approval For BSX Device

Natick's Boston Scientific Corp. announced that the U.S. Food and Drug Administration has approved a new device...
ADVERTISEMENT

BSX ‘Disappointed’ By Suit

Natick-based Boston Scientific Corp. says it's "disappointed" by a new civil lawsuit filed by the U.S. Department...

Qteros Lands $22M, Inks Partnership

On Jan. 4, Qteros, the 50-person biofuel-development startup in Marlborough, announced a strategic partnership with an Indian...
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

December Flash Sale! Get 40% off new subscriptions from now until December 19th!

Close the CTA

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA